Domestic 7-ACA makers bracing for lower export price

Published: 2003-07-18 06:58:00

Updated: 2003-07-18 06:58:00

Korea's pharmaceutical makers producing 7-ACA (7-aminocephalosporanic acid), an intermediate of cephalosporin antibiotic, are now striving to cope with its lower pricing of $98.0 kg offered by Chinese counterparts this year, even though the normal price of such bulk material was in the level of $...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK